I'm specifically talking the day after approval, but most people are aware of the companies massive failings and last chance saloon shots because they have been belt fed this for the last 3 years.
A. Look at what just happened the day after Botanics FDA approval, up barely 10% and they had a CRL for the label only.
B. Yes BOT did a CAP raise, but I can see MSB doing exactly the same thing. They will need cash around Jan 2025.
C. Neuren on their FDA approval also, up 19% the next day.
I think MSB has generated a bad reputation for itself not gaining approval, and a lot of people will wait to see it generate revenues before jumping in.... just like what is happening with BOT right now.
Post approval sure it will hit $2 and I would be extremely dissaponted too if it didn't, I just no longer think that is a possibility the day after.
2024 Here we go again., page-757
-
- There are more pages in this discussion • 121 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.17 |
Change
-0.010(0.85%) |
Mkt cap ! $1.347B | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.18 | $1.16 | $244.6K | 209.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 33330 | $1.17 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.17 | 16169 | 6 |
View Market Depth
| Last trade - 10.15am 17/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |